Journal Article Summary
The article investigates the relationship between platelet turnover and the risk of major adverse cardiovascular events (MACE) following percutaneous coronary intervention (PCI) with stent implantation. This topic is important because high platelet reactivity, which can be influenced by elevated platelet turnover, is linked to adverse cardiovascular outcomes. Understanding how platelet turnover affects patient outcomes can help improve risk assessment and management strategies in patients undergoing PCI, potentially leading to better clinical outcomes.
In this study, researchers analyzed data from 486 patients who underwent PCI and were treated with dual antiplatelet therapy (aspirin and clopidogrel). They measured platelet turnover using two specific markers: mean platelet volume (MPV) and reticulated platelet fraction (RPF). The findings revealed that RPF was a significant predictor of MACE, with higher levels associated with an increased risk of these events. In fact, patients with an RPF of 3.35% or higher had a nearly doubled risk of MACE compared to those with lower levels. Additionally, RPF was also linked to an increased risk of bleeding complications during hospitalization.
However, the study has limitations, including its observational design and the focus on patients only receiving aspirin and clopidogrel, which may not apply to those on newer antiplatelet therapies. Patients and caregivers should discuss the implications of platelet turnover with healthcare professionals, especially regarding the potential risks of MACE and bleeding after PCI. Understanding these factors can help in making informed decisions about treatment and monitoring strategies post-procedure.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Freynhofer Matthias K., Iliev Liana, Bruno Veronika, Rohla Miklos, Egger Florian, Weiss Thomas W., Hübl Wolfgang, Willheim Martin, et al.. Platelet Turnover Predicts Outcome after Coronary Intervention. Thrombosis and Haemostasis 2017. DOI: 10.1160/TH16-10-0785. PMID: 28229159. PMCID: PMC5442606.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
